Trials / Conditions / Anthracycline-induced Cardiotoxicity
Anthracycline-induced Cardiotoxicity
6 registered clinical trials studyying Anthracycline-induced Cardiotoxicity — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial NCT07442578 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection NCT07528586 | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | N/A |
| Not Yet Recruiting | Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients NCT07254221 | Shiraz University of Medical Sciences | Phase 4 |
| Unknown | Late Anthracycline Induced Cardiotoxicity- Childhood Cancer Survivors NCT04852965 | Queen's University, Belfast | — |
| Completed | Preventing Cardiac Sequelae in Pediatric Cancer Survivors NCT01805778 | The Hospital for Sick Children | — |
| Completed | Spironolactone Against Anthracycline-induced Cardiomyopathy NCT02053974 | TC Erciyes University | Phase 4 |